Insider Transactions in Q2 2021 at Sage Therapeutics, Inc. (SAGE)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2021
|
Barry E Greene President and CEO |
BUY
Open market or private purchase
|
Direct |
8,800
+50.0%
|
$492,800
$56.32 P/Share
|
|
Jun 16
2021
|
Kevin P Starr |
BUY
Open market or private purchase
|
Direct |
17,842
+5.27%
|
$999,152
$56.05 P/Share
|
|
Jun 16
2021
|
James M Frates |
BUY
Open market or private purchase
|
Indirect |
1,810
+50.0%
|
$99,550
$55.1 P/Share
|
|
Jun 16
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+4.3%
|
$2,000
$1.36 P/Share
|
|
Jun 16
2021
|
Jeffrey M Jonas |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+13.76%
|
$0
$0.45 P/Share
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.9%
|
$47,676
$58.8 P/Share
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+7.47%
|
-
|
|
Jun 15
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.0%
|
$3,000
$1.36 P/Share
|
|
Jun 15
2021
|
Stephen Kanes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,001
-8.49%
|
$58,058
$58.8 P/Share
|
|
Jun 15
2021
|
Stephen Kanes Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+22.89%
|
-
|
|
Jun 15
2021
|
Albert Robichaud Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-0.81%
|
$66,352
$58.8 P/Share
|
|
Jun 15
2021
|
Albert Robichaud Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+2.76%
|
-
|
|
Jun 15
2021
|
Jeffrey M Jonas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,093
-4.66%
|
$179,394
$58.8 P/Share
|
|
Jun 15
2021
|
Jeffrey M Jonas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+13.1%
|
-
|
|
Jun 15
2021
|
Anne Marie Cook SVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,144
-18.7%
|
$66,352
$58.8 P/Share
|
|
Jun 15
2021
|
Anne Marie Cook SVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+39.54%
|
-
|
|
Apr 13
2021
|
Kimi Iguchi CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+3.91%
|
$1,500
$1.36 P/Share
|